137 related articles for article (PubMed ID: 22161472)
1. Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.
Matsumoto-Takasaki A; Hanashima S; Aoki A; Yuasa N; Ogawa H; Sato R; Kawakami H; Mizuno M; Nakada H; Yamaguchi Y; Fujita-Yamaguchi Y
J Biochem; 2012 Mar; 151(3):273-82. PubMed ID: 22161472
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
Sakai K; Yuasa N; Tsukamoto K; Takasaki-Matsumoto A; Yajima Y; Sato R; Kawakami H; Mizuno M; Takayanagi A; Shimizu N; Nakata M; Fujita-Yamaguchi Y
J Biochem; 2010 Jun; 147(6):809-17. PubMed ID: 20147453
[TBL] [Abstract][Full Text] [Related]
3. Renewed interest in basic and applied research involving monoclonal antibodies against an oncofetal Tn-antigen.
Fujita-Yamaguchi Y
J Biochem; 2013 Aug; 154(2):103-5. PubMed ID: 23740330
[TBL] [Abstract][Full Text] [Related]
4. Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
Yuasa N; Ogawa H; Koizumi T; Tsukamoto K; Matsumoto-Takasaki A; Asanuma H; Nakada H; Fujita-Yamaguchi Y
J Biochem; 2012 Apr; 151(4):371-81. PubMed ID: 22318767
[TBL] [Abstract][Full Text] [Related]
5. Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.
Zamri N; Masuda N; Oura F; Yajima Y; Nakada H; Fujita-Yamaguchi Y
Biosci Trends; 2012 Dec; 6(6):303-12. PubMed ID: 23337790
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.
Morita N; Yajima Y; Asanuma H; Nakada H; Fujita-Yamaguchi Y
Biosci Trends; 2009 Feb; 3(1):32-7. PubMed ID: 20103942
[TBL] [Abstract][Full Text] [Related]
7. Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells.
Zamri N; Masuda N; Oura F; Kabayama K; Yajima Y; Nakada H; Yamamoto K; Fujita-Yamaguchi Y
Biosci Trends; 2013 Oct; 7(5):221-9. PubMed ID: 24241172
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy.
Osinaga E; Bay S; Tello D; Babino A; Pritsch O; Assemat K; Cantacuzene D; Nakada H; Alzari P
FEBS Lett; 2000 Mar; 469(1):24-8. PubMed ID: 10708749
[TBL] [Abstract][Full Text] [Related]
9. In-site interaction evaluation of Tn density by inhibition/competition assays.
Robles A; Medeiros A; Berois N; Balter HS; Pauwels EK; Osinaga E
Nucl Med Biol; 2010 May; 37(4):453-8. PubMed ID: 20447557
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL).
Mortezai N; Behnken HN; Kurze AK; Ludewig P; Buck F; Meyer B; Wagener C
Glycobiology; 2013 Jul; 23(7):844-52. PubMed ID: 23507963
[TBL] [Abstract][Full Text] [Related]
12. MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.
Shuck SC; Hong T; Kalkum M; Igarashi R; Kajiya K; Termini J; Yamamoto K; Fujita-Yamaguchi Y
Biosci Trends; 2019 Jul; 13(3):216-224. PubMed ID: 31168022
[TBL] [Abstract][Full Text] [Related]
13. A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity.
Welinder C; Baldetorp B; Borrebaeck C; Fredlund BM; Jansson B
Glycobiology; 2011 Aug; 21(8):1097-107. PubMed ID: 21470982
[TBL] [Abstract][Full Text] [Related]
14. Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.
Ando H; Matsushita T; Wakitani M; Sato T; Kodama-Nishida S; Shibata K; Shitara K; Ohta S
Biol Pharm Bull; 2008 Sep; 31(9):1739-44. PubMed ID: 18758069
[TBL] [Abstract][Full Text] [Related]
15. Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.
Koizumi T; Matsumoto-Takasaki A; Nakada H; Nakata M; Fujita-Yamaguchi Y
Biosci Trends; 2010 Dec; 4(6):308-11. PubMed ID: 21248428
[TBL] [Abstract][Full Text] [Related]
16. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
[TBL] [Abstract][Full Text] [Related]
18. Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen.
Vichier-Guerre S; Lo-Man R; Bay S; Deriaud E; Nakada H; Leclerc C; Cantacuzène D
J Pept Res; 2000 Feb; 55(2):173-80. PubMed ID: 10784033
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
